Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Jan. 31, 2019	Jan. 31, 2018
Cash Flows from Operating Activities:
Net income (loss)	$ (4,544,627)	$ 1,524,823
Adjustments to reconcile net income (loss) to net cash provided by (used in) operations:
Depreciation and amortization	2,351,722	2,284,340
Change in fair value of commodity derivative instruments	(44,228)	113,233
Gain on sale of assets		(24,815)
Changes in operating assets and liabilities:
Commodity derivative instruments	735,556	130,421
Accounts receivable	1,611,324	179,702
Inventory	84,362	(495,390)
Prepaid expenses and other current assets	(538,574)	(341,310)
Accounts payable	(5,789,620)	(2,550,585)
Accrued expenses	(37,320)	226,774
Net Cash Provided by (Used in) Operating Activities	(6,171,405)	1,047,193
Cash Flows from Investing Activities:
Payments for capital expenditures	(332,814)	(569,982)
Proceeds from disposal of assets		24,815
Net Cash Used in Investing Activities	(332,814)	(545,167)
Cash Flows from Financing Activities:
Payments on long-term debt	(7,763)	(110,844)
Checks drawn in excess of bank balance		1,151,278
Distributions to non-controlling interests		(4,311,192)
Member distributions paid	(1,196,000)	(11,779,102)
Net Cash Used in Financing Activities	(1,203,763)	(15,049,860)
Net Decrease in Cash and Restricted Cash	(7,707,982)	(14,547,834)
Cash and Restricted Cash - Beginning of Period	14,901,091	21,733,611
Cash and Restricted Cash - End of Period	7,193,109	7,185,777
Cash paid during the period for:
Interest expense	113,663	105,755
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Capital expenditures and construction in process included in accounts payable	$ 18,291	$ 63,829